Your Search Results

Which way to choose?

18 May 2021 – From EuroPCR 2021

Watch this video to check whether you would have opted for the same vessel and the same strategy when facing this NSTEMI case.

Treating complex coronary lesions: right case right time Prevail™ DCB

01 Oct 2021 – From AICT-AsiaPCR 2021

Thanks to this session, find out more about indications for drug-coated balloons, or, on the contrary, learn when not to use it. And through the analysis of two concrete cases, see how DCB can be an important tool to tackle increasingly complex patients and anatomies, especially...

Treating complex coronary lesions: right case right time Prevail™ DCB

Telescope guide extension catheter in complex coronary interventions

01 Oct 2021 – From AICT-AsiaPCR 2021

View the complex case of this 70-year-old male patient with hypertension and diabetes who presented with chest pain and NSTEMI, which shows that, when dealing with challenging calcific disease, guide catheter extensions help improve device delivery.

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

01 Oct 2021 – From AICT-AsiaPCR 2021

In this session dedicated to the MASTER DAPT study, considered the largest HBR trial to date, learn about the baseline characteristics, clinical presentation, and procedural characteristics of this large trial carried out across 4 continents, before hearing our speakers' interpretation of its 30-days outcomes.

MASTER DAPT trial: dual antiplatelet therapy after coronary stenting in high bleeding risk patients

Renal denervation in the real-world: performance in high risk subgroups

05 Oct 2021 – From AICT-AsiaPCR 2021

After having evoked in particular the SPRAL HTN Global Clinical Program, the RDN consensus statements, the EHS position paper 2021, the ARDeC, and the STEP Trial, Tzung-Dau Wang shares his experience in using renal denervation to manage uncontrolled hypertension by illustrating his words with the case...

Putting evidence in clinical practice of managing high-bleeding risk (HBR) patients

06 Oct 2021 – From AICT-AsiaPCR 2021

In this video, Aaron Wong and Paul Ong share their views on the contribution of various stents to the treatment of HBR patients and the value of durable, biodegradable, non-polymer stents in specific cases. They base their discussion on the results of numerous studies on stents using...

Putting evidence in clinical practice of managing HBR patients

TAVI procedure optimisation with the cusp overlap technique

27 Sep 2021 – From PCR Tokyo Valves 2021

In this session, the speakers present the advantages of the cusp overlap technique, providing a technical overview, and predicting that it will lead to best-in-class permanent pacemaker implantation rates, and will also have a great impact on paravalvular leak rates and other clinical endpoints. They further support their point by...

TAVI procedure optimisation with the cusp overlap technique

Introducing Navitor: a new TAVR solution with an active paravalvular leak-sealing technology

27 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to view the live case from Copenhagen of a 77-year-old woman with severe aortic valve stenosis NYHA III, to get a precise description of the features of the Navitor system and the Naviseal technology, a new solution for reducing risk of paravalvular leak,...

Addressing the challenges of small annuli patients with the Evolut Platform

27 Sep 2021 – From PCR Tokyo Valves 2021

Recognizing that Asian patients, especially women with aortic stenosis, are smaller and have smaller annuli than European ones, for instance, this session discusses the challenges of treating these patients, among them prosthesis patient mismatch, annulus rupture, coronary occlusion, or vascular complication. In addition, the speakers will draw...

Addressing the challenges of small annuli patients with the Evolut Platform

Case-based challenging heart team decisions in combined structural heart diseases

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this case-based session on combined structural heart diseases to discover what is the heart team approach for complex structure heart diseases, as well as how to manage a patient with multiple diseases.

Case-based challenging heart team decisions in combined structural heart diseases

Contemporary procedural practice for TAVI

25 Sep 2021 – From PCR Tokyo Valves 2021

Watch this session to learn more about contemporary procedural practice for TAVI: discover the impact of the COVID-19 pandemic on TAVI programmes worldwide, the steps of contemporary transfemoral TAVI with tips and tricks, as well as the rules for early discharge post TAVI.

Transcatheter tricuspid valve interventions: the future

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session, observe the case of an 84-year-old, not overweight, quite active, female patient with a past history of restrictive cardiomyopathy and permanent atrial fibrillation, who presented with worsening dyspnea and obvious clinical signs of right ventricular heart failure, and discuss the...

Transcatheter tricuspid valve interventions: the future

Commissural alignment for TAVI

23 Nov 2021 – From PCR London Valves 2021

In this PCR London Valves 2021 session shot in the simulation lab, learn tips and tricks for achieving commissural alignment, review the strategy for improving TAVR outcomes, and discuss how to get the right imaging, the right tools, and the right patients.

Closing Ceremony

23 Nov 2021 – From PCR London Valves 2021

Looking back on some of the key moments of the PCR London Valves 2021, it is clear that we witnessed cutting-edge procedures in all three valves, pushed the guidelines to the limits and beyond, saw the future of valve procedures with a new TAVI device implanted, live-implanted...

Transcatheter mitral edge-to-edge repair: procedural complications and lifetime management

23 Nov 2021 – From PCR London Valves 2021

This PCR London Valves 2021 session presents different kinds of complications in mitral procedures based on clinical cases: discuss the case of an 82-year-old male patient with symptomatic severe ischemic secondary mitral regurgitation, coronary artery disease, diabetes, and chronic kidney disease, among others!